ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 200,000 Value ($000) $260 Avg Close — Range —
Q4 2024
Shares 1,435,000 Value ($000) $1,525 Avg Close — Range —
Q3 2024
Shares 1,480,000 Value ($000) $1,730 Avg Close — Range —
Q2 2024
Shares 1,930,000 Value ($000) $2,080 Avg Close — Range —
Q1 2024
Shares 70,600,000 Value ($000) $66,341 Avg Close — Range —
Q4 2023
Shares 74,600,000 Value ($000) $73,625 Avg Close — Range —
Q3 2023
Shares 74,600,000 Value ($000) $68,738 Avg Close — Range —